Search Results - Joe Conner

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Inconsistencies in Modeling the Efficacy of the Oncolytic Virus HSV1716 Reveal Potential Predictive Biomarkers for Tolerability by Faith Howard, Joe Conner, Sarah Danson, Munitta Muthana

    Published in Frontiers in Molecular Biosciences (2022-06-01)
    Get full text
    Article


  2. 2

    HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib <i>In Vitro</i> and Significantly Reduces Systemic Tumor Growth in Mouse Models by Simon Tazzyman, Georgia R. Stewart, James Yeomans, Adam Linford, Darren Lath, Joe Conner, Munitta Muthana, Andrew D. Chantry, Michelle A. Lawson

    Published in Viruses (2023-02-01)
    Get full text
    Article


  3. 3

    High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to Chemotherapy by Leslee Sprague, Joel M. Lee, Brian J. Hutzen, Pin-Yi Wang, Chun-Yu Chen, Joe Conner, Lynne Braidwood, Kevin A. Cassady, Timothy P. Cripe

    Published in Viruses (2018-03-01)
    Get full text
    Article


  4. 4

    Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion by Julia V. Cockle, Anke Brüning-Richardson, Karen J. Scott, Jill Thompson, Timothy Kottke, Ewan Morrison, Azam Ismail, Angel M. Carcaboso, Ailsa Rose, Peter Selby, Joe Conner, Susan Picton, Susan Short, Richard Vile, Alan Melcher, Elizabeth Ilett

    Published in Molecular Therapy: Oncolytics (2017-06-01)
    Get full text
    Article


  5. 5

    Macrophage Delivered HSV1716 Is Active against Triple Negative Breast Cancer by Amy Kwan, Faith Howard, Natalie Winder, Emer Atkinson, Ameera Jailani, Priya B. Patel, Richard Allen, Penelope D. Ottewell, Gary C. Shaw, Joe Conner, Caroline Wilson, Sanjay K. Srivastava, Sarah J. Danson, Claire Lewis, Janet E. Brown, Munitta Muthana

    Published in Future Pharmacology (2022-10-01)
    Get full text
    Article


Search Tools: